138
Participants
Start Date
January 31, 2019
Primary Completion Date
September 5, 2024
Study Completion Date
September 5, 2024
Sacubitril/valsartan
Target dose 97/103 mg b.i.d .
Akershus University Hospital, Lørenskog
Stavanger University Hospital, Stavanger
University of North Norway, Tromsø
St Olavs Hospital, Trondheim
Collaborators (1)
University Hospital, Akershus
OTHER
Oslo University Hospital
OTHER
University Hospital of North Norway
OTHER
St. Olavs Hospital
OTHER
Helse Stavanger HF
OTHER_GOV
Klinbeforsk
OTHER
Norwegian Cancer Society
OTHER
Novartis
INDUSTRY
Torbjorn Omland
OTHER